04.05.2024 |
Nanoparticle Delivery of Therapeutic NF1 Signaling ERPs to Schwann Cells
04.05.2024 |
Optimization of Base and Prime Editing Strategies for NF1 Therapeutics
04.05.2024 |
Optimized AAV Vectors for Therapeutic Schwann Cell Targeting in NF1
04.05.2024 |
Testing the Efficacy of New NF1 Gene Therapy Candidates in Human Cell Types
04.05.2024 |
Exon Skipping to Treat NF1 – Phase B
04.05.2024 |
Targeted Delivery of Full Length NF1 cDNA Using Non-Viral Vectors
04.05.2024 |
Exploring Nonsense Suppression as a Treatment for NF1 – Phase B
04.05.2024 |
Disrupting FBXW11-Mediated Degradation of NF1 to Rescue Haploinsufficiency
04.05.2024 |
RAFT-Polymerized Nanoparticles for Delivery of NF1 cDNA to Schwann Cells
04.05.2024 |
Genome Editing for the Treatment of Neurofibromatosis Type I
03.27.2024
Detroit Future City Releases New Report: “Keeping Your Family Home: Addressing the Challenges of Inherited Properties in Detroit”
Read
